<DOC>
	<DOCNO>NCT02126514</DOCNO>
	<brief_summary>This study open-label , non-randomized , absorption , metabolism , excretion study evaluate mass balance , metabolite profile , rate route elimination [ 14C ] -AZD3293 derive metabolite follow administration single 100-mg ( contain approximately 150 µCi ) oral dose ( oral solution )</brief_summary>
	<brief_title>A Phase I , Open-Label , Single-Center Study Assess Absorption , Metabolism , Excretion 14C-AZD3293</brief_title>
	<detailed_description>This study open-label , non-randomized , absorption , metabolism , excretion study evaluate mass balance , metabolite profile , rate route elimination [ 14C ] -AZD3293 derive metabolite follow administration single 100-mg ( contain approximately 150 µCi ) oral dose ( oral solution ) follow least 8-hour fast food ( include water ) . Seven healthy male subject enrol study single study site complete minimum 6 subject . The study consist 2 visit .</detailed_description>
	<criteria>Healthy male subject 18 55 year age , inclusive , time consent suitable vein cannulation repeat venipuncture ; 2 ) Body weight 50 100 kg , inclusive ; 3 ) Within BMI range 19 30 kg/m2 , inclusive ; 4 ) In good health , determine clinically significant finding medical history , physical examination neurological examination , 12lead ECG , vital sign judge Investigator ; Participation prior study AZD3293 previous enrollment present study ; 2 ) Significant history clinical manifestation metabolic , allergic , dermatological , hepatic , renal , hematological , pulmonary , cardiovascular , GI , neurological , psychiatric disease disorder , opinion Investigator , may either put subject risk participation study , interfere absorption , distribution , metabolism excretion drug , influence result subject 's ability participate study ; 3 ) History significant hypersensitivity , intolerance , allergy drug compound , food , substance , unless approve Investigator ;</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Beta secretase inhibitor</keyword>
	<keyword>Alzheimer disease</keyword>
</DOC>